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Use of Two-dimensional Multiple-slice Magnetic
Resonance Hydrography for Diagnosis of Hepatic
Hemangiomas and Cysts
Ran-Chou Chen,1,2* Chao-Shiang Li,2 Chen-Te Chou,1 Wei-Tsung Chen,2
Chao-Jung Wei,3 Jiunn-Ming Lii,2 Hsing-Yang Tu2
Background/Purpose: Although hepatic hemangiomas and cysts display very high signal intensities on
conventional T2 images, their appearances are quite distinct using magnetic resonance hydrography
(MRH). We examined the feasibility of using MRH in distinguishing hepatic cysts from hemangiomas.
Methods: We recruited 97 patients with hepatic hemangiomas and 65 with hepatic cysts. All patients un-
derwent magnetic resonance imaging (including two-dimensional multiple slice MRH, TR/TE: 8000/800)
and the results were reviewed independently by two radiologists. The signal intensities of the lesions were
measured. For each lesion, the variation in signal to noise ratio between MRH and the fat-saturated T2-
weighted images was calculated, and the results were validated using a receiver operating characteristic curve.
Results: There was a significant difference between the signal to noise ratio of hepatic hemangiomas and
cysts using MRH (p < 0.001). This difference could be identified by visual inspection. The receiver operat-
ing characteristic curve revealed that the ideal cut-off value for the signal intensity reduction ratio between
hepatic cysts and hemangiomas was −0.1. Using this ratio, the derived sensitivity was 95.4%, specificity
99.0%, and accuracy 99.7%.
Conclusion: Hepatic hemangiomas and cysts have significantly different signal intensities on non-contrast
two-dimensional multiple-slice MRH. This approach uses a non-invasive, reliable, and accurate imaging
technique to differentiate the two diagnoses.
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Magnetic resonance hydrography (MRH) is the
imaging of static and slow-flowing fluid using an
magnetic resonance imaging (MRI) device.1,2 MRH
has made possible various valuable clinical inves-
tigations in abdominal and pelvic regions, namely
MR cholangiopancreatography,3 MR urography,
and MRH of the fetus.4
Although hepatic cysts and hemangiomas
display very high signal intensities (SIs) on con-
ventional T2 images, their appearances are quite
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distinct using MRH. Specifically, hepatic cysts
have very high SI on heavily weighted T2 MRH,
and hepatic hemangiomas display only a mar-
ginally higher intensity. Previous studies have
suggested that for a 1.5T MRI device, the relax-
ation time of hemangiomas is 140–178 millisec-
onds, whereas that of hepatic cysts is 341–517
milliseconds.5,6 The use of true fast imaging with
steady-state precision and half-Fourier acquisition
single-shot turbo spin echo (HASTE) to depict
liver tumors, including hemangiomas, has been
reported.7 However, hepatic cysts and heman-
giomas are still usually confirmed by contrast-
enhanced MR studies. Recently, the hazards of
using gadolinium-based MR contrast agent have
been highlighted.8 According to a previous study,
the incidence of nephrogenic systemic fibrosis
was 0.7% with high-dose gadolinium-based con-
trast medium, which increased to 0.4% in chronic
renal disease.9 Ideally, both of these benign con-
ditions should be diagnosed without the use of
an MR contrast agent.
The use of two-dimensional (2D) multiple-
slice MRH for the differentiation of hepatic cysts
from hemangiomas has not yet been completely
documented. Therefore, the purpose of this
study was to investigate the feasibility of MRH 
as a non-contrast alternative that supplements
routine MR pulse sequences to increase the diag-
nostic accuracy for these two common hepatic
lesions.
Patients and Methods
The study had the approval of the institutional
review boards of our hospital. Informed consent
for participation in the study was obtained from
all patients prior to MR examination.
Patients
This study was conducted over 11 months.
Patients who were found to have focal hepatic
tumors by sonography and for whom further as-
sessment was indicated, were referred for MRI. 
A total of 109 patients were found to have lesions
that had a “light-bulb” appearance on T2-weighted
imaging. The light-bulb appearance was defined
as very high, internal homogeneous SI (similar
to the signal of the thecal sac) and well-defined
margins on T2-weighted imaging (T2WI).10 The
appearance of all the lesions was confirmed by
the on-site radiologist (R.C. Chen, C.S. Li, W.T.
Chen or J.M. Li). An additional MRH sequence
was performed on the above patients. Focal le-
sions > 1.0 cm were included to avoid the partial
volume effect. For patients with multiple lesions,
only the largest three from each patient were in-
cluded. The results revealed 99 patients with 97
hepatic hemangiomas and 65 hepatic cysts. The
diagnosis of hepatic cyst relied on its characteristic
MR findings, which included a low T1 and a very
high T2 SI without enhancement in a contrast-
enhanced series. Hemangioma was confirmed 
by its distinctive MR characteristics, which was 
a very high T2 SI, enhanced in a peripherally
nodular or rapidly homogeneous pattern during
the early arterial phase, followed by fill-in or per-
sistent homogeneity during the late and delayed
phases.11,12
The diameter of the hemangiomas ranged from
1.0 cm to 4.6 cm (mean: 1.9 ± 1.1 cm) and the di-
ameter of the cysts varied from 1.0 cm to 6.5 cm
(mean: 2.2±1.5 cm). After their MR examinations,
all patients were followed up by sonography for
a minimum of 6 months (range: 6–18 months).
The largest diameters of the lesions were recorded
for comparison.
Imaging
Sonographic examinations were performed with
a Logiq 700 sonography unit (GE Medical Sys-
tems, Milwaukee, WI, USA) using a 3.5–4.0 MHz
probe. MR images were acquired using a 1.5T MR
scanner (Philips Gyroscan ACS-NT, Eindhoven,
the Netherlands) and a phased-array body coil.
Dual T1-weighted images (TR/TE: 210/2.3 and
4.6; slice thickness, 8 mm; gap, 0.8 mm; matrix,
256 × 204; axial) were performed within one
breath hold. Turbo spin-echo (TSE) T2-weighted
images (TR/TE: 1800–2500/100; TSE factor, 
23; NSA, 4; slice thickness, 8 mm; gap, 0.8 mm;
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matrix, 256 × 154; axial), with and without fat
saturation, and coronal T2-weighted images were
obtained with respiratory triggering.
The MRH was an axial 2D single shot, with
multi-slice sequences and fat saturation, which
was acquired within one breath hold (TR/TE,
8000/800; TSE factor, 128; 12 slices; slice thick-
ness, 8 mm; gap, 0.8 mm, matrix, 256 × 204;
NSA, 2). The total acquisition time was only 16
seconds and all patients were examined using
the same technique. The total thickness of 
tissue scanned for each 2D MRH session was typ-
ically 10 cm. Using the above parameters, the en-
tire liver could be scanned within two breath
holds.
Dynamic MR images were obtained by applying
a T1-weighted fast field echo sequence (175–210/
1.3–2.1; flip angle, 80°; NSA, 1; slice thickness,
8 mm; gap, 0.8 mm; matrix, 256 × 154) before in-
travenous contrast administration and at 18–20
seconds (early arterial-dominant phase), 50–55
seconds (portal venous phase), and 5 minutes
(5-minute delayed phase) after the manual intra-
venous administration of gadopentetate dime-
glumine (Magnevist; Schering, Berlin, Germany;
0.1 mmol/kg body weight). Other delayed phase
axial images and coronal images were acquired
about 10 minutes after intravenous contrast agent
administration (10-minute delayed phase). These
pulse sequences were all obtained using single
acquisitions during one breath hold.
Image analysis
The task of image analysis was subdivided between
three separate radiologists who were blinded to
the lesion type. One measured the mean value of
SI of the lesions of the fat-saturated T2WI and
MRH. This was performed on a picture archiving
and communication system (PACS; Centricity
Radiology RA600 v6.1 Diagnostic; GE Medical
Systems) with a high-resolution monitor using an
operator-defined region of interest that was de-
fined as an ovoid area 5–10 mm in diameter. The
standard deviation (SD) of background noise was
measured in a background area anterior to the
lesion without phase-shift artifacts. The signal to
noise ratio (SNR = SI/SDbackground) of the lesions
in the two series were calculated.
Two radiologists independently reviewed all
MR images in two steps without prior knowledge
of diagnosis. The images were pre-set to the opti-
mal window level and center, and sent to the PACS
by the technologists. The non-contrast images in-
cluding MRH were given to the radiologists for
review, and they were asked to record the SI of the
lesions on T2-weighted fat-saturated images and
MRH based on the pre-set images. They were not
allowed to change the window level and centers.
The SI of the lesions was graded as isointense, in-
termediate hyperintense, or very hyperintense as
compared to the SI of the liver parenchyma. Next,
they were asked to compare the SIs in the three se-
ries and record the changes between the MRH and
other pulse sequences, and then to make a diagno-
sis by visual inspection. If the SI of the lesion by
MRH was comparable with or higher than that by
fat-saturated T2WI, it was labeled a hepatic cyst.
If the reverse occurred and the MRH SI of the lesion
was lower than that of the fat-saturated T2WI, the
lesion was regarded as a hemangioma. The signal
for hemangioma was low, but all the lesions were
still visible by MRH. To establish the reference stan-
dard, the radiologists reviewed all sonographic
and MR images (including the dynamic MR im-
ages with contrast enhancement) as well as the
follow-up sonography and/or MR images, to reach
a consensus. The established diagnosis was re-
corded separately from the preliminary diagnoses
based on visual inspection.
Statistical analysis
For statistical analysis of the SNR of the lesions in
the different MR series, we used the Student t test.
A p value < 0.05 was considered to be statistically
significant. The signal variation ratio of the SNRs
of the lesions between MRH and T2WI with fat
saturation defined by the formula
SNR(MRH) − SNR(T2 fat sat)/SNR(T2 fat sat). The re-
sultant variation derived from this formula was
evaluated and validated by a ROC curve from
which an ideal cut-off value was obtained. Thus,
lesions with SI variation that fell beneath the 
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cut-off value were diagnosed as hemangiomas,
and those with SI variation above the cut-off value
were considered to be hepatic cysts. The sensitivity
and specificity of this method were also obtained
from the ROC curve. In addition, the sensitivity
and specificity of the visual assessment by two ra-
diologists were calculated and the inter-observer
variation was analyzed by the κ test.
Results
All diagnoses of hepatic hemangiomas and cysts
were confirmed by contrast-enhanced MRI. All of
the cysts were hypointense by T1-weighted imag-
ing, hyperintense by T2WI, and did not enhance
throughout the study. All of the hemangiomas
were hypointense by T1-weighted imaging, hy-
perintense by T2WI, and demonstrated one of
two types of enhancement. One type of enhance-
ment was rapid, homogeneous, and persisted into
the delayed phase.11,12 The other was progressive
centripetal enhancement that also persisted into
the delayed phase. There was no disagreement
between the two radiologists over the final diag-
noses of the hemangiomas and cysts.
For the preliminary diagnosis based on their
visual assessment of SI variations, the first radiol-
ogist successfully diagnosed 96 out of 97 hepatic
hemangiomas and 63 out of 65 hepatic cysts.
The sensitivity was 98.97%, the specificity was
96.92%, and the accuracy was 98.15%. The second
radiologist was able to make the correct diagnoses
in all the 97 hemangiomas and 64 of the 65 cysts
with a sensitivity of 100%, specificity of 98.46%,
and accuracy of 99.38%. The inter-observer agree-
ment was excellent (κ = 0.948). There were four
disagreements in which three of the lesions were
cysts and one of the lesions was hemangioma.
The mean size of these four lesions was relatively
small at 1.1 cm (range: 1.0–1.3 cm).
We also attempted to quantify the SI variation
that distinguished the two lesions. For heman-
giomas, the mean SNR was 80.80 ± 38.45 on the
fat-saturated T2-weighted images and 17.09 ±
8.79 on the MRH images (Figure 1). For cysts,
the SNR was 98.74 ± 44.07 on the fat-saturated
T2-weighted images and 215.03 ± 107.11 on the
MRH images (Figure 2). Using the Student t test,
the difference in SNR variation between the he-
mangiomas and cysts was consistent and statisti-
cally significant (p<0.001). Based on this analysis,
MRH was clearly a superior approach to conven-
tional MR when discriminating these two lesions.
The variation ratio calculated by the equation
SNR(MRH) − SNR(T2 fat sat)/SNR(T2 fat sat) was differ-
ent for the hemangiomas and cysts. A ratio of 
−0.1 was a good cut-off value for discriminating
hemangiomas and cysts, and this allowed only a
few exceptions (Figure 3). This meant that le-
sions with SI reduction ratio < −0.1 should have
been considered to be hemangiomas, whereas le-
sions for which the ratio was > −0.1 should have
been diagnosed as cysts. The area under the ROC
curve was 0.997. Quantitative analysis of the MRH
results with respect to differentiation of heman-
gioma from cysts revealed a sensitivity of 95.4%,
a specificity of 99.0%, and an accuracy of 99.7%.
There were five exceptions using −0.1 as the cut off
value: three cysts and two hemangiomas. For four
lesions, this might have been caused by the rela-
tively high standard deviation of the background
noise (three cysts with high SD by MRH and one
hemangioma with high SD by fat-saturated T2WI).
One hemangioma (SI reduction ratio = −0.1) fell
in the borderline area of the cut off value.
Discussion
Hepatic hemangiomas and cysts are very common
benign hepatic lesions, most of which can be diag-
nosed by sonography.13,14 However, difficulties can
arise with some obese patients.14,15 These are usu-
ally diagnosed by contrast-enhanced MRI. Some
atypical hemangiomas can show marked delay
in enhancement, and in these cases 10-minute
delayed scans are needed, thus prolonging the
MR study.16 For some small hemangiomas, their
T2-weighted SIs are bright, yet they can be diffi-
cult to identify in the T1-weighted images before
and after contrast enhancement due to their size.
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For these atypical or small hemangiomas, MRH,
which is quick and easy to perform in nearly all
MR machines and does not require additional
contrast medium, might be a helpful method for
their characterization.
MRH is able to highlight static or very slow-
flowing fluid by applying a heavily T2-weighted
pulse sequence. In Fenlon’s study, extreme T2WI
with a TE of 125 milliseconds was useful for distin-
guishing benign and malignant hepatic lesions.17
Other investigators have also used heavily T2-
weighted MRI and true fast imaging with steady-
state precision sequences to differentiate hepatic
cysts and hemangiomas from other solid tu-
mors.7,18,19 Jafari et al have measured the T1 and
T2 SIs of liver, spleen and hemangioma using a
rapid acquisition relaxation enhanced sequence
with a 0.5T MR device, setting the TE at 500 mil-
liseconds.20 They noted that even with the TE set
at 500 milliseconds, the SI of the hemangioma
remained high. In view of this phenomenon, we
increased the TE to 800 milliseconds for our 2D
multiple slice MRH, and a significant drop in the
signal intensity of the hemangiomas could be
noticed compared to that with the cysts; this phe-
nomenon can be confidently recognized by visual
inspection.
Hepatic lesions with a light-bulb appearance
by T2WI were the lesions of interest in our study.
All lesions with a light-bulb appearance were either
cysts or hemangiomas. Traditionally, to diagnose
these during an MR scan involves the use of a
contrast agent, which has recently been found to
be associated with nephrogenic systemic fibrosis in
patients with renal insufficiency.21,22 On the other
hand, contrast agent is seldom used in routine
health examinations, to avoid any possible reac-
tion. Both lesions are benign; therefore, the use of
A B
C D
Figure 1. Magnetic resonance imaging in a 37-year-old woman showed hepatic hemangioma. (A) Axial T2-weighted and
(B) axial T2-weighted with fat saturation MR images showed a very high-signal hepatic hemangioma (arrow). (C)
Magnetic resonance hydrography (8000/800) showed a significant signal drop (arrow) compared with (A) and (B). (D)
The post-contrast delayed-phase T1-weighted image showed homogeneous enhancement of the lesion (arrow).
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a potentially hazardous agent in their diagnosis
is not appropriate. Nevertheless, despite the fact
that both diagnoses are benign, patients often
prefer to have a definite diagnosis.23 MRH offers a
fast (16 seconds) and reliable method for the dif-
ferentiation of cysts from hemangiomas, without
the use of an MR contrast agent.
To remove the confounding factor of indige-
nous SI differences in different lesions, the differ-
ence between SIs of the lesions using MRH and
fat-saturated T2WI was expressed as a ratio. It was
mentioned that the ideal cut-off value was −0.1
according to the ROC curve and the dot diagram.
This gave MRH a sensitivity of 95.4%, a speci-
ficity of 99.0%, and an accuracy of 99.7%. This
ideal cut off value will vary depending on the MR
facility and the parameters used. However, quali-
tative assessment by radiologists using the naked
eye gave comparable results. Therefore, we sug-
gest that MRH is an excellent tool for differenti-
ating hepatic hemangiomas from cysts and that
qualitative assessment should suffice in day-to-
day practice.
A B
C D
Figure 2. A 56-year-old women with multiple hepatic cysts. (A) Axial T2-weighted and (B) axial T2-weighted with fat 
saturation magnetic resonance images showed multiple hepatic cysts. (C) MR hydrography (8000/800) showed a per-
sistent high T2 signal for all the cysts. (D) The post-contrast late-phase T1-weighted magnetic resonance image showed
negative enhancement in these lesions.
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Figure 3. The signal intensity variation ratio of the magnetic
resonance hydrography and T2 fat-saturated images was
calculated using SI(MRH) − SI(T2 fat sat)/SI(T2 fat sat). The ideal
cut-off value was found to be −0.1. Almost all hemangiomas
were<−0.1, whereas almost all cysts were >−0.1. SI= signal
intensity; MRH=magnetic resonance hydrography.
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One study has explored the feasibility of differ-
entiating hepatic cysts from hemangiomas using
multi-section fluid-attenuated inversion recovery
(FLAIR)-HASTE.24 This MR technique appears to
be helpful; however, it faces a particular dilemma.
In that study, only 85% of the cysts could be null
effectively by FLAIR-HASTE.24 In our study, the
accuracy of MRH was 98.15–99.7%. Therefore, we
suggest that MRH seems to be a more reliable
technique when differentiating these two lesions.
In our current day-to-day practice, delayed-
phase post-contrast MRI sequences are still occa-
sionally required for confirmation of hepatic cysts
or hemangiomas and the exclusion of other le-
sions.25 This typically adds 5–10 minutes to the
study duration. In comparison, MRH does not
require contrast enhancement, takes only 16 sec-
onds for 12 images, and can be done as an add-on
as soon as the prior MR sequences reveal sus-
picious hepatic lesions. Most importantly, it is
both sensitive and specific, with or without ROI
measurement.
One of the limitations of the present study was
that all the hemangiomas and cysts were typical
cases. Jang et al have reported several atypical he-
mangiomas that could not be differentiated from
malignant tumors by computed tomography,
conventional MR, and sonography.16 It would be
interesting to investigate the MR hydrographic
appearance of such sclerosed or hemorrhagic he-
mangiomas. Future investigation in this area would
be helpful. However, the present study still pro-
vided a rapid MR sequence that helped with the
diagnosis of cysts and hemangiomas without the
use of contrast medium. Another limitation was
that pathological examination was not available.
This was a study of hepatic benign lesions such as
cysts and hemangiomas. All of them showed char-
acteristic MR appearances and no interval changes
during the 6–18 months follow-up studies. This
is a shortcoming in most comparative studies.26
There were inter-observer discrepancies in the
preliminary diagnosis of four lesions; all of
which were relatively small. This discrepancy
might have been due to the relatively thick 2D
slices (8 mm) and the resultant partial volume
artifacts. This can be easily mitigated by employ-
ing a three-dimensional method that is able to
achieve a much thinner slice thickness, although
at the expense of a longer examination time of
4–8 minutes.3,27 However, the accuracy of the
present study was high. Thus a time-consuming
three-dimensional method might not be neces-
sary given such a satisfactory result.
In conclusion, hepatic lesions with a light-
bulb appearance in T2WI are almost always cysts
or hemangiomas. These two types of lesions, even
if they are small in size (the smallest was 1.0 cm),
can be reliably differentiated by 2D multiple-slice
MRH. This is a fast and reliable technique and
does not require the administration of potentially
hazardous gadolinium chelates. Hemangiomas
demonstrate a noticeable signal drop during
MRH, whereas cysts retain a light-bulb appearance.
The sequence is useful for the patients who can-
not use gadolinium chelate contrast agents and
for those who receive MR health examinations.
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